Skip to content
Drug development in the rare disease space has seen a vast amount of innovation in recent years, with a number of groundbreaking therapies coming […]
Goodwin Rare Disease Symposium: ‘So much opportunity, so much unmet need’ Read More »
Seeking biotech-friendly policy from the new administration and Congress will be daunting and perhaps confusing, but there are still a lot of potential wins
BIO CEO 2025: Challenges and opportunities in the new administration Read More »
Reforms to prevent middlemen from driving up drug prices and legislation encouraging the development of oral medications and rare disease treatments were called top
What BIO’s watching in the new Congress Read More »
Legislation introduced last year to ease widespread commercialization of sustainable aviation fuel (SAF) was reintroduced Jan. 16 as one of the early measures proposed
Farm to Fly Act reintroduced in Senate would give SAF wings Read More »
Pharmacy benefit managers (PBMs) make billions in profit while driving up the price of prescription drugs with markups that can exceed 1,000%, according to
FTC’s second report on PBMs blasts drug price markups of 1,000% Read More »
As science progresses, we need parallel progress in making breakthrough treatments widely available, BIO President & CEO John F. Crowley said at a Jan.
BIO CEO urges innovation in access at White House CGT forum Read More »
Federal officials said they withdrew plans for new regulation of genetically engineered (GE) crops on U.S. wildlife refuges due to the outcry by numerous
How BIO’s comments affected regulations on genetically engineered crops Read More »
The 10-year-old girl was cheerful and upbeat as she spoke to a group of strangers online, but she was also disarmingly clear-eyed about the
Children with rare diseases advocate for legislation in online panel Read More »
Legislation to increase transparency of pharmacy benefit managers (PBMs), and to reauthorize the Pediatric Priority Review Voucher (PPRV), the Pandemic All Hazards Preparedness Act
Congress set to pass PBM reform and extensions of PPRV, PAHPA, Farm Bill Read More »
Proposed federal rules on exchange of medical data with China and five other “countries of concern” can protect Americans without obstructing the global flow
Data transfer rules don’t have to hamper biotech innovation, BIO says Read More »
